Fauconnier Jérémy, Lacampagne Alain, Rauzier Jean-Michel, Fontanaud Pierre, Frapier Jean-Marc, Sejersted Ole M, Vassort Guy, Richard Sylvain
Physiolpatholgie Cardiovascularie, Institut National de la Santé et de la Recherche Médicale U-637, Université Montpellier 1, Montpellier, France.
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H778-86. doi: 10.1152/ajpheart.00542.2004. Epub 2004 Oct 7.
FK-506, a widely used immunosuppressant, has caused a few clinical cases with QT prolongation and torsades de pointe at high blood concentration. The proarrhytmogenic potential of FK-506 was investigated in single rat ventricular cells using the whole cell clamp method to record action potentials (APs) and ionic currents. Fluorescence measurements of Ca2+ transients were performed with indo-1 AM using a multiphotonic microscope. FK-506 (25 micromol/l) hyperpolarized the resting membrane potential (RMP; -3 mV) and prolonged APs (AP duration at 90% repolarization increased by 21%) at 0.1 Hz. Prolongation was enhanced by threefold at 3.3 Hz, and early afterdepolarizations (EADs) occurred in 59% of cells. EADs were prevented by stronger intracellular Ca2+ buffering (EGTA: 10 vs. 0.5 mmol/l in the patch pipette) or replacement of extracellular Na+ by Li+, which abolishes Na+/Ca2+ exchange [Na+/Ca2+ exchanger current (INaCa)]. In indo-1-loaded cells, FK-506 generated doublets of Ca(2+) transients associated with increased diastolic Ca2+ in one-half of the cells. FK-506 reversibly decreased the L-type Ca2+ current (ICaL) by 25%, although high-frequency-dependent facilitation of ICaL persisted, and decreased three distinct K+ currents: delayed rectifier K+ current (IK; >80%), transient outward K+ current (<20%), and inward rectifier K+ current (IK1; >40%). A shift in the reversal potential of IK1 (-5 mV) accounted for RMP hyperpolarization. Numerical simulations, reproducing all experimental effects of FK-506, and the use of nifedipine showed that frequency-dependent facilitation of ICaL plays a role in the occurrence of EADs. In conclusion, the effects of FK-506 on the cardiac AP are more complex than previously reported and include inhibitions of IK1 and ICaL. Alterations in Ca2+ release and INaCa may contribute to FK-506-induced AP prolongation and EADs in addition to the permissive role of ICaL facilitation at high rates of stimulation.
FK-506是一种广泛使用的免疫抑制剂,在高血药浓度时已引发了几例QT间期延长和尖端扭转型室速的临床病例。采用全细胞膜片钳法记录动作电位(APs)和离子电流,在单个大鼠心室肌细胞中研究了FK-506的促心律失常潜力。使用多光子显微镜,采用indo-1 AM对Ca2+瞬变进行荧光测量。FK-506(25微摩尔/升)使静息膜电位(RMP)超极化(-3毫伏),并在0.1赫兹时延长动作电位(动作电位在90%复极化时的时程增加21%)。在3.3赫兹时,动作电位延长增强了三倍,59%的细胞出现早期后去极化(EADs)。更强的细胞内Ca2+缓冲(膜片钳微管中EGTA:10与0.5毫摩尔/升)或用Li+替代细胞外Na+可防止EADs的发生,Li+可消除Na+/Ca2+交换[Na+/Ca2+交换电流(INaCa)]。在装载indo-1的细胞中,FK-506在一半的细胞中产生与舒张期Ca2+增加相关的Ca(2+)瞬变双峰。FK-506使L型Ca2+电流(ICaL)可逆性降低25%,尽管ICaL的高频依赖性易化持续存在,并且降低了三种不同的K+电流:延迟整流K+电流(IK;>80%)、瞬时外向K+电流(<20%)和内向整流K+电流(IK1;>40%)。IK1反转电位的偏移(-5毫伏)导致RMP超极化。重现FK-506所有实验效应的数值模拟以及硝苯地平的使用表明,ICaL的频率依赖性易化在EADs的发生中起作用。总之,FK-506对心脏动作电位的影响比先前报道的更为复杂,包括对IK1和ICaL的抑制。除了在高刺激频率下ICaL易化的允许作用外,Ca2+释放和INaCa的改变可能有助于FK-506诱导的动作电位延长和EADs。